Lobbying on Strategic approach to pharmaceuticals in the environment

Strategic approach to pharmaceuticals in the environment

Links

ID: 1386

Lobbying Activity

15 responses

Consultation response

European Environmental Bureau, 26 May 2017

The European Environmental Bureau welcomes the publication of the roadmap “Strategic approach to pharmaceuticals in the environment” as the European Union needs to tackle with urgency the environmental and heath risks posed by the the release of active pharmaceutical ingredients (API) to the…

Consultation response

European Federation of Pharmaceutical Industries and Associations, 26 May 2017

The European pharmaceutical industry represented by AESGP, EFPIA and Medicines for Europe support the Roadmap objectives of filling knowledge gaps, exploring how to protect the environment and safeguarding patient access to pharmaceutical treatments. The objectives are aligned with our…

Consultation response

BDEW Bundesverband der Energie- und Wasserwirtschaft e. V., 24 May 2017

Der BDEW begrüßt die Veröffentlichung des Fahrplanes zum strategischen Ansatz der EU über Arzneimittelrückstände in der Umwelt. Unter diesem Aspekt wird die Kommission gebeten die öffentliche Stakeholder-Konsultation zeitnah zu veröffentlichen, um die Einbindung wichtiger Akteure in den…

Consultation response

SUEZ Group, 26 May 2017

Dear Madam, Sir, Please find attached the contribution of SUEZ to the consultation on the Roadmap "Strategic approach to pharmaceuticals in the environment". We hope our input will contribute in a constructive way to the work of the European Commission. Should you have any questions, do not…

Consultation response

AnimalhealthEurope, 26 May 2017

IFAH-Europe welcomes the opportunity to comment on the new EU Commission Roadmap on a Strategic Approach to Pharmaceuticals in the Environment and looks forward to participating in future consultation activities. We support the intent to protect the environment and at the same time safeguard…

Consultation response

European Federation of National Associations of Water Services, 19 May 2017

Micropollutants are a challenge for waste water operators, whose mission is to treat waste water to ensure the protection of the environment and ecosystems, and for drinking water operators, who have to rely on drinking water resources to produce drinking water. Micropollutants can enter the…

Consultation response

Bureau Brussel Vewin - Unie van Waterschappen, 23 May 2017

Vewin, the Association of Dutch Water Companies, welcomes this opportunity to react to this Roadmap. Pharmaceutical products are essential to our society’s health and their use is likely to increase in the future due to a growing and ageing population. The issue of pharmaceutical residues, as…

Consultation response

Health Care Without Harm Europe, 22 May 2017

Health Care Without Harm Europe (HCWH) Europe is a European network of hospitals and healthcare systems, local authorities, healthcare professionals, and environmental and health organisations. HCWH Europe is a non-profit, membership-based organisation, located in Brussels that currently counts 82…

Consultation response

Coalition Clean Baltic, 26 May 2017

Coalition Clean Baltic (CCB) is a regional network of grass root environmental NGOs committed to protection and improvement of the environment of the Baltic Sea catchment area. The network was established in 1990 and includes 18 member organizations representing the main largest environmental…

Consultation response

Pestizid Aktions-Netzwerk e.V., 24 May 2017

PAN Germany welcomes the Commissions’ initiative to draft a roadmap for a Strategic approach to pharmaceuticals in the environment. We appreciate that the focus is laid on the whole lifecycle of pharmaceuticals, that it looks at environmental and health issues of human and veterinary…

Consultation response

Stockholms universitet, 26 May 2017

We welcome the Commission’s initiative to reduce harmful effects of pharmaceuticals in the environment and believe that the issue needs to be addressed at several stages of the lifecycle of a pharmaceutical substance. Important upstream measures include facilitating for public procurement to put…

Consultation response

European Sustainable Phosphorus Platform, 12 May 2017

The possible presence of pharmaceuticals in processed sewage biosolids and animal manures is a significant potential obstacle to the Circular Economy for nutrients (recycling to agriculture of phosphorus, nitrogen, other nutrients) and to the return of carbon from these sources to soil (important…

Consultation response

Advanced Bioprocess Development Limited, 26 May 2017

I am providing feedback through my experience and expertise as a researcher at Manchester Metropolitan University (MMU) and Managing Director of MMU spin-out company, Advanced Bioprocess Development Ltd. (ABD). These views do not necessarily represent those of MMU. ABD has developed a tertiary…

Consultation response

Stichting Huize Aarde, 26 May 2017

One of the first steps for a roadmap should be the use and definition of crucial concepts to be applied for policy making. With the right definition of the concepts to be used, the direction for thinking and acting will be determined. Pharmaceuticals in the environment Emphasis lies on the…

Consultation response

Senior Corporate Silver Spoon, Environment & Nature Association/Ezüstkanál Nyugdíjas Társasági, Környezet- és természetvédelmi Egyesület, 8 May 2017

Dear Lady/Sir, Responding to the roadmap described below, I will give the following answer: The best strategy is to create a flexible approach to the natural environment that is environmentally friendly. The decision makers adapt flexibly to the environment, not just to the natural…